Check your travel medical
New orca rescue attempt
Student's killer on parole
Joly urges de-escalation 
No bail in Ottawa killings 
Banks must say rebate
Iran fires at attack drones 
World's largest election 
2 detained in Volkov attack 
Apple pulls apps from China
Oil and gas leases restricted
Indigo needs turnaround 
Warriors ready for Round 2
Kalamalka Bowl cancelled
Rockets live to fight on
Hilton teams up with Sia
Swift still 'can't forgive' Kim
Grimes to ‘cap the disarray’
NEW YORK, - Pfizer says it does not intend to make a takeover offer for British drugmaker AstraZeneca.
The announcement Monday comes a week after AstraZeneca’s board rejected a proposed $119-billion buyout offer from Pfizer, the world’s second-biggest drugmaker by revenue.
Pfizer Chairman and CEO Ian Read says the company’s final proposal represented full value for AstraZeneca.
Pfizer, the maker of Lipitor and Viagra, has been courting No. 8 AstraZeneca since January, saying their businesses would be stronger together.
Pfizer had been waiting for AstraZeneca to engage in merger talks by a Monday deadline.
Pfizer has previously said it would not make a hostile takeover bid directly to AstraZeneca’s stockholders.
